Schrodinger/$SDGR

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX

About Schrodinger

Schrodinger Inc is a healthcare-based software company. Its operating segments are Software and Drug discovery. Through the Software segment, the company is focused on selling software to transform drug discovery across the life sciences industry and customers in materials science industries. In the Drug discovery segment, it is engaged in generating revenue from a portfolio of preclinical and clinical programs, internally and through collaborations. It generates revenue from the sales of software solutions and from research funding and milestone payments from its drug discovery collaborations.

Ticker

$SDGR
Sector
Primary listing

Employees

891

Schrodinger Metrics

BasicAdvanced
$1.5B
-
-$2.48
1.68
-

What the Analysts think about Schrodinger

Analyst ratings (Buy, Hold, Sell) for Schrodinger stock.

Bulls say / Bears say

Q2 2025 total revenue increased 16% year-over-year to $54.8 million, beating consensus expectations of $52.03 million, driven by 15% growth in software and 19% growth in drug discovery (GuruFocus News)
Net loss narrowed to $43.2 million in Q2 2025 from $54.0 million in the previous year, with EPS at -$0.59 surpassing the estimate of -$0.88, showing improved operational efficiency (GuruFocus News)
The company ended Q2 2025 with $462 million in cash and equivalents, providing a strong foundation to support its software expansion and drug discovery pipeline (Investing.com)
Software gross margin fell to 68% in Q2 2025 from 80% a year earlier, pressured by costs related to the predictive toxicology initiative (GuruFocus News)
Total operating expenses remained high at $79.1 million in Q2 2025, despite a 6% year-over-year reduction, extending the company’s cash burn risk (The Motley Fool)
Drug discovery revenue growth partially reflects recognition of a one-time $150 million upfront payment from the Novartis collaboration, raising concerns about future sustainability when milestone payments slow (Investing.com)
Data summarised monthly by Lightyear AI. Last updated on 4 Oct 2025.

Schrodinger Financial Performance

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

Schrodinger Earnings Performance

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $SDGR

Sign up or log in to buy
Capital at risk
Market closed

Upcoming events

No upcoming events
FAQs
Buy Schrodinger stock | $SDGR Share Price | Lightyear